Beijing Strong Biotechnologies,Inc.

Equities

300406

CNE100001Y26

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E. Other stock markets 23:00:00 14/05/2024 BST			5-day change	1st Jan Change
17.63 ^CNY	-1.01%		-5.01%	-7.70%

04-28	Beijing Strong Biotechnologies,Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-25	Beijing Strong Biotechnologies,Inc. Announces Final Cash Dividend (Tax Included) (A Shares) for 2023, Payable on 07 May 2024	CI

Tranche Update on Beijing Strong Biotechnologies, Inc.'s Equity Buyback Plan announced on March 7, 2022.

October 09, 2022 at 05:00 pm

From July 1, 2022 to September 30, 2022, the company has repurchased 872,300 shares, representing 0.15% for CNY 15 million. With this, the company has completed the repurchase of 1,718,200 shares, representing 0.29% for CNY 29.99 million under the buyback announced on March 7, 2022.

Latest news about Beijing Strong Biotechnologies,Inc.

Beijing Strong Biotechnologies,Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-28	CI
Beijing Strong Biotechnologies,Inc. Announces Final Cash Dividend (Tax Included) (A Shares) for 2023, Payable on 07 May 2024	04-24	CI
Beijing Strong Biotechnologies,Inc. Proposes Final Cash Dividend for 2023	04-01	CI
Tranche Update on Beijing Strong Biotechnologies,Inc.'s Equity Buyback Plan announced on July 21, 2023.	04-01	CI
Beijing Strong Biotechnologies,Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-29	CI
Tranche Update on Beijing Strong Biotechnologies,Inc.'s Equity Buyback Plan announced on July 21, 2023.	01-03	CI
Tianfu Energy Chairman Proposes Buyback of Up to 30 Million Yuan Shares	12-13	MT
Neo-Neon CFO Steps Down; Successor Named	11-20	MT
ASIA COPPER WEEK-China to expand imports of scrap copper -industry association	11-15	RE
Beijing Strong Biotechnologies,Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023	24/10/23	CI
Tranche Update on Beijing Strong Biotechnologies,Inc.'s Equity Buyback Plan announced on July 21, 2023.	11/10/23	CI
Beijing Strong Biotechnologies,Inc. Approves Executive Appointments	25/09/23	CI
Beijing Strong Biotechnologies, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	09/08/23	CI
Beijing Strong Biotechnologies, Inc. announces an Equity Buyback for CNY 80 million worth of its shares.	21/07/23	CI
Beijing Strong Biotechnologies, Inc. authorizes a Buyback Plan.	20/07/23	CI
Beijing Strong Biotechnologies, Inc. Announces Dividend on Share A for 2022, Payable on May 22, 2023	16/05/23	CI
Beijing Strong Biotechnologies, Inc. Approves Cash Dividend for 2022	12/05/23	CI
Beijing Strong Biotechnologies, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	27/04/23	CI
Beijing Strong Biotechnologies, Inc. Proposes Final Cash Dividend for the Year 2022	20/04/23	CI
Beijing Strong Biotechnologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	19/04/23	CI
Tranche Update on Beijing Strong Biotechnologies, Inc.'s Equity Buyback Plan announced on March 7, 2022.	07/12/22	CI
Beijing Strong Biotechnologies, Inc.'s Equity Buyback announced on May 7, 2022, has expired with 2,867,000 shares, representing 0.49% for ¥50 million.	06/12/22	CI
Beijing Strong Biotechnologies, Inc. Reports Earnings Results for the Nine Months Ended September 30, 2022	27/10/22	CI
Factbox-China's new political elites and their connection to Xi	24/10/22	RE
'Alarm Bells' Ring as China Shuffles Economic Leaders at Critical Time	10/10/22	MT

Chart Beijing Strong Biotechnologies,Inc.

Duration

Period

Chart Beijing Strong Biotechnologies,Inc.

More charts

Company Profile

Beijing Strong Biotechnologies Inc. is a China-based company mainly engaged in the research and development, manufacture and sales of in vitro diagnostic reagents. The Companyâs in vitro diagnostic reagents are mainly used in liver, renal, blood fat, glycometabolism and other fields. The Company is also engaged in the manufacture and sales of in vitro diagnostic equipment and the leasing of equipment. The Company operates businesses in domestic and overseas markets.

Sector

Medical Equipment, Supplies & Distribution

Calendar

29/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Beijing Strong Biotechnologies,Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

17.63

Average target price

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Diagnostic & Testing Substances

	1st Jan change	Capi.
BEIJING STRONG BIOTECHNOLOGIES,INC.	-7.70%	1.43B
BIOMÉRIEUX	-4.62%	12.32B
DIASORIN S.P.A.	+8.48%	5.87B
LANTHEUS HOLDINGS, INC.	+28.39%	5.52B
AUTOBIO DIAGNOSTICS CO., LTD.	-6.28%	4.29B
10X GENOMICS, INC.	-52.84%	3.16B
ANDON HEALTH CO., LTD.	+12.93%	2.72B
MYRIAD GENETICS, INC.	+28.84%	2.23B
VITROLIFE AB	-3.80%	2.37B
GUANGZHOU WONDFO BIOTECH CO.,LTD	-4.64%	1.87B

Diagnostic & Testing Substances